Read out on Dep Docetaxel and part of Dep Cabazitaxel
Dep Gemcitabine entering the clinic
Further expansion of indications in clinic for AZD0466
Phase 1/2 combination arm of DEP® irinotecan + 5-FU + Leucovorin (‘FOLFIRI’entering the clinic
TGA approval for Viraleze in Australia
New partnership agreement with radiotherapeutics
Merck beginning first in human clinical trials with ADC's
FDA NDA update
Monetising undisclosed former blockbuster drug of Astrazeneca with Starpharma's improved version
Sacking of Mundipharma and finding a real partner
Licensing our internal in house Dep drugs
The above is a realistic list of things that I believe can occur over the next 4-5 months
Of course there are many other possibilities..........
Look forward to a very productive quarter
- Forums
- ASX - By Stock
- Looking forward to the following leading up to AGM
Read out on Dep Docetaxel and part of Dep Cabazitaxel Dep...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.004(4.40%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.2¢ | $81.30K | 864.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 0.095 |
2 | 110498 | 0.094 |
1 | 26688 | 0.092 |
1 | 49413 | 0.091 |
4 | 122750 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |